Nucleus RadioPharma is appointing Mark Przekop as the company's chief operating officer (COO) to lead supply chain strategy initiatives.
Przekop has over 35 years of experience in the nuclear pharmacy and radiopharmaceuticals industry, including commercial and operational experience in supply chain networks, marketing, and regulatory compliance oversight. Prior to joining Nucleus, Przekop held multiple roles at ARTMS, most recently as COO. He was also vice president of pharmacy services at Jubilant Radiopharma.
Nucleus recently closed its recent oversubscribed $56 million series A funding round to increase the accessibility of radiopharmaceuticals to cancer patients. The company said that this, along with the supply chain strategies Prsekop will lead, aims to continue bringing treatments to cancer patients.